Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Pr ...
Abstract
Authors
CA Pichardo-Piña JL Sánchez-Casillas JC Pozos-Espíndola